Citations

Showing 10 of 107930 citations.

Targeting Pyk2 for therapeutic intervention
Loftus, Joseph C. , Lipinski, Christopher A.

Mayo Clinic

Expert Opinion on Therapeutic Targets | December 9, 2009 | Volume: 14 | Issue: 1 | Pages: 95-108

10.1517/14728220903473194 | PMID 20001213 Get It

Gene Networks and microRNAs Implicated in Aggressive Prostate Cancer
Tang, Hui , Thayanithy, Venugopal, Subramanian, Subbaya , Oberg, Ann L. , Cunningham, Julie M. , Cerhan, James R. , Steer, Clifford J. , Thibodeau, Stephen N. , Wang, Liang , Cerhan, James R

Mayo Clinic

Cancer Research | December 8, 2009 | Volume: 69 | Issue: 24 | Pages: 9490-9497

10.1158/0008-5472.can-09-2183 | PMID 19996289 Get It

Abstract Prostate cancer, a complex disease, can be relatively harmless or extremely aggressive. To identify candidate genes involved in causal pathways of aggressive prostate cancer, we implemented a systems biology approach by combining differential expression analysis and coexpression network analysis to evaluate transcriptional profiles using lymphoblastoid cell lines from 62 prostate cancer patients with aggressive phenotype (Gleason grade ≥ 8) and 63 prostate cancer patients with nonaggressive phenotype (Gleason grade ≤ 5). From 13,935 mRNA genes and 273 microRNAs (miRNA) tested, we identified significant differences in 1,100 mRNAs and 7 miRNAs with a false discovery rate (FDR) of <0.01. We also identified a coexpression module demonstrating significant association with the aggressive phenotype of prostate cancer (P = 3.67 × 10−11). The module of interest was characterized by overrepresentation of cell cycle–related genes (FDR = 3.50 × 10−50). From this module, we further defined 20 hub genes that were highly connected to other genes. Interestingly, 5 of the 7 differentially expressed miRNAs have been implicated in cell cycle regulation and 2 (miR-145 and miR-331-3p) are predicted to target 3 of the 20 hub genes. Ectopic expression of these two miRNAs reduced expression of target hub genes and subsequently resulted in cell growth inhibition and apoptosis. These results suggest that cell cycle is likely to be a molecular pathway causing aggressive phenotype of prostate cancer. Further characterization of cell cycle–related genes (particularly, the hub genes) and miRNAs that regulate these hub genes could facilitate identification of candidate genes responsible for the aggressive phenotype and lead to a better understanding of prostate cancer etiology and progression. [Cancer Res 2009;69(24):9490–7]
Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6
Tiedemann, Rodger E. , Zhu, Yuan Xiao , Schmidt, Jessica, Yin, Hongwei , Shi, Chang-Xin, Que, Qiang, Basu, Gargi D. , Azorsa, David O. , Perkins, Louise M. , Braggio, Esteban , Fonseca, Rafaël , Bergsagel, P. Leif , Mousses, Spyro, Stewart, A. Keith , Bergsagel, P. Leif , Braggio, Esteban , Fonseca, Rafael

Mayo Clinic

Blood | December 8, 2009 | Volume: 115 | Issue: 8 | Pages: 1594-1604

10.1182/blood-2009-09-243980 | PMID 19996089 Get It

AbstractA paucity of validated kinase targets in human multiple myeloma has delayed clinical deployment of kinase inhibitors in treatment strategies. We therefore conducted a kinome-wide small interfering RNA (siRNA) lethality study in myeloma tumor lines bearing common t(4;14), t(14;16), and t(11;14) translocations to identify critically vulnerable kinases in myeloma tumor cells without regard to preconceived mechanistic notions. Fifteen kinases were repeatedly vulnerable in myeloma cells, including AKT1, AK3L1, AURKA, AURKB, CDC2L1, CDK5R2, FES, FLT4, GAK, GRK6, HK1, PKN1, PLK1, SMG1, and TNK2. Whereas several kinases (PLK1, HK1) were equally vulnerable in epithelial cells, others and particularly G protein–coupled receptor kinase, GRK6, appeared selectively vulnerable in myeloma. GRK6 inhibition was lethal to 6 of 7 myeloma tumor lines but was tolerated in 7 of 7 human cell lines. GRK6 exhibits lymphoid-restricted expression, and from coimmunoprecipitation studies we demonstrate that expression in myeloma cells is regulated via direct association with the heat shock protein 90 (HSP90) chaperone. GRK6 silencing causes suppression of signal transducer and activator of transcription 3 (STAT3) phosphorylation associated with reduction in MCL1 levels and phosphorylation, illustrating a potent mechanism for the cytotoxicity of GRK6 inhibition in multiple myeloma (MM) tumor cells. As mice that lack GRK6 are healthy, inhibition of GRK6 represents a uniquely targeted novel therapeutic strategy in human multiple myeloma.
Src-Mediated Phosphorylation of Dynamin and Cortactin Regulates the “Constitutive” Endocytosis of Transferrin
Cao, Hong , Chen, Jing , Krueger, Eugene W. , McNiven, Mark A.

Mayo Clinic

Molecular and Cellular Biology | December 8, 2009 | Volume: 30 | Issue: 3 | Pages: 781-792

10.1128/mcb.00330-09 | PMID 19995918 Get It

INTRAMEDULLARY SJÖGREN SYNDROME
Chahin, Salim , Garwood, M. D., Louis, Erik K. St. , Shivapour, E. Torage, Kelkar, Praful , Granner, Mark A. , St Louis, E K

Mayo Clinic

Neurology | December 8, 2009 | Volume: 73 | Issue: 23 | Pages: 2041-2042

10.1212/wnl.0b013e3181c55ced | PMID 19996081 Get It

HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
Brum, Doralina Guimarães , Barreira, Amilton Antunes , Kaimen-Maciel, Damacio Ramón , Matiello, Marcelo , Deghaide, Neifi Hassan Saloun, Costa, Laudo Silva, Louzada‐Júnior, Paulo , Diniz, Paula Rejane Beserra , Mendes‐Junior, Celso Teixeira , Donadi, Eduardo Antônio , Santos, Antônio Carlos dos , Costa, Roberta Martins da Silva , Comini-Frota, Elizabeth Regina

Mayo Clinic

Multiple Sclerosis Journal | December 7, 2009 | Volume: 16 | Issue: 1 | Pages: 21-29

10.1177/1352458509350741 | PMID 19995845 Get It

Until recently, neuromyelitis optica (NMO) was considered to be a sub-type of multiple sclerosis (MS), which has a strong predilection for Caucasian populations, whereas NMO is more frequent in non-Caucasian individuals. The objective of this study was to compare the HLA-DRB profile in Brazilian Mulatto patients with NMO spectrum disorders (NMOSDs) with that observed for Mulatto MS patients and healthy Mulatto controls. Twenty seven NMOSD patients (20 women), all seropositive for NMO-IgG, 29 MS patients and 28 Mulatto healthy blood donors were evaluated for HLA-DRB allele groups. HLA-DRB1*03 allele group was overrepresented in NMO patients compared with healthy controls (p = 0.0401; OR = 3.23, 95%CI: 1.07—9.82). In contrast, the HLA-DRB1*15 allele group was overrepresented in Brazilian MS patients (OR = 15.89, 95%CI: 3.51—71.85; p < 0.0001). DRB3 was overrepresented in NMO (p = 0.0064), and DRB5 overrepresented in MS patients (p = 0.0001). The low frequency of HLA-DRB1*15 alleles was associated with the presence of long and central cord lesions at magnetic resonance. In addition, DRB1*15 alleles were associated with the fulfillment of the Barkhof criteria. In conclusion, these results indicate that the DRB profile of NMO patients is different from that observed for MS patients, further corroborating the distinction between NMO and MS.
Structural and Functional Characterization of Hla-Dr Molecules Circulating in the Serum
Jendro, M. C., Weyand, Cornelia M. , Goronzy, Jörg J.

Mayo Clinic

Autoimmunity | December 7, 2009 | Volume: 8 | Issue: 4 | Pages: 289-296

10.3109/08916939109007636 | PMID 1932513 Get It

Soluble Hia-Dr Molecules in Patients with Hla Class II Versus Class I Associated Disorders
Weyand, Cornelia M. , Jendro, M. C., Goronzy, Jörg J.

Mayo Clinic

Autoimmunity | December 7, 2009 | Volume: 8 | Issue: 4 | Pages: 281-287

10.3109/08916939109007635 | PMID 1932512 Get It

Thyrotropin Secretion in Mild and Severe Primary Hypothyroidism Is Distinguished by Amplified Burst Mass and Basal Secretion with Increased Spikiness and Approximate Entropy
Roelfsema, Ferdinand , Pereira, Alberto M. , Adriaanse, Ria, Endert, Erik , Fliers, Eric , Romijn, Johannes A. , Veldhuis, Johannes D.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 5, 2009 | Volume: 95 | Issue: 2 | Pages: 928-934

10.1210/jc.2009-1959 | PMID 19965923 Get It

Effect of Posteroinferior Capsule Tightness on Contact Pressure and Area beneath the Coracoacromial Arch during Pitching Motion
Muraki, Takayuki , Yamamoto, Nobuyuki , Zhao, Kristin D. , Sperling, John W. , Steinmann, Scott P. , Cofield, Robert H. , An, Kai‐Nan , Trentadue, Taylor P

Mayo Clinic

The American Journal of Sports Medicine | December 4, 2009 | Volume: 38 | Issue: 3 | Pages: 600-607

10.1177/0363546509350074 | PMID 19966101 Get It

Background Tightness of the posteroinferior capsule is assumed to be the cause of internal rotation loss in baseball pitchers. Although the relationship between posterior capsule and subacromial impingement has been recognized, this relationship during the baseball-pitching motion is unclear. Hypothesis Contact pressure during baseball-pitching motion increases with posterior capsule tightness. Study Design Controlled laboratory study. Methods Eight fresh-frozen shoulders were used. The peak contact pressure and area on the coracoacromial arch were measured on a custom-designed shoulder experimental device capable of 6 degrees of freedom motion. Simultaneously, the sites of peak pressure on the coracoacromial arch and humerus were observed from various angles. The posteroinferior capsule tightness was simulated by plicating the capsule in the region from 6 to 8 o'clock. The static testing positions correlated to the early cocking, late cocking, acceleration, deceleration, and follow-through phases of the pitching motion. Results The peak contact pressure during the follow-through phase (0.63 ± 0.50 MPa) significantly increased with posteroinferior capsule tightness (1.00 ± 0.65 MPa) (P = .014). Additionally, the contact area on the coracoacromial ligament during the follow-through phase (0.98 ± 0.67 cm2) significantly increased with posteroinferior capsule tightness (1.47 ± 0.91 cm 2) (P < .001). The site of the peak contact pressure did not change between the 2 conditions. Conclusion Our findings demonstrate that posteroinferior capsule tightness leads to higher contact pressure under the subacromial arch and increased contact area, particularly on the coracoacromial ligament during the follow-through phase. Clinical Relevance This tightness may affect risk of injury of the rotator cuff and its surrounding tissues by increasing subacromial contact during pitching.